4 results
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
-
- Journal:
- Antimicrobial Stewardship & Healthcare Epidemiology / Volume 3 / Issue 1 / 2023
- Published online by Cambridge University Press:
- 30 June 2023, e116
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey
-
- Journal:
- Antimicrobial Stewardship & Healthcare Epidemiology / Volume 3 / Issue 1 / 2023
- Published online by Cambridge University Press:
- 31 March 2023, e63
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Lessons learned: Development of COVID-19 clinical staging models at a large urban research institution
-
- Journal:
- Journal of Clinical and Translational Science / Volume 7 / Issue 1 / 2023
- Published online by Cambridge University Press:
- 27 March 2023, e113
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Universal admission testing with a rapid molecular point-of-care test and real-time polymerase chain reaction (PCR) assay for the detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Comparative performance and infection prevention implications
-
- Journal:
- Infection Control & Hospital Epidemiology / Volume 44 / Issue 1 / January 2023
- Published online by Cambridge University Press:
- 18 October 2022, pp. 138-140
- Print publication:
- January 2023
-
- Article
-
- You have access
- Open access
- HTML
- Export citation